Investors.sightsciences.com

Sight Sciences Announces TearCare® Clinical Data Published in …

WebClinical trial data being used to seek expanded indication from the FDA. MENLO PARK, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. …

Actived: 9 days ago

URL: https://investors.sightsciences.com/news-releases/news-release-details/sight-sciences-announces-tearcarer-clinical-data-published

Sight Sciences Announces Withdrawal of Final LCDs on Micro …

WebDecision ensures continued access to comprehensive outflow procedure enabled by OMNI® Surgical System technology for glaucoma patients. MENLO PARK, …

Category:  Health Go Health

Sight Sciences Reports Third Quarter 2023 Financial Results and

WebMENLO PARK, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused …

Category:  Health Go Health

Sight Sciences Announces the Publication of Large-Scale, Real …

Web“Consistent with our many prior published studies, this large-scale, real-world MIGS dataset from the IRIS Registry, as analyzed by Verana Health ® and published in …

Category:  Health Go Health

Sight Sciences Announces the Publication of Twelve-Month …

Weba Mann-Whitney rank sum test. b P<.001 vs Study baseline. Month 9 and 12 visits are 3 and 6 months post-cross-over from CsA to TC. OD and OS measurements …

Category:  Health Go Health